FDA’s Decentralized Trial Guidance: Investigator, Health Care Provider Demarcation Raises Questions

 
• By Brenda Sandburg
  
Clinical trial
FDA guidance on decentralized clinical trials focuses on the role of local healthcare providers. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D